Max Wallace, CEO of Accelerate Brain Cancer Cure, provides perspective on the latest Avastin trial results by Genentech.
A Unique Opportunity To Learn About The Most Innovative New Trends In Brain Tumor Research.
A blog post from Max Wallace, CEO of Accelerate Brain Cancer Cure.
Max Wallace, CEO of Accelerate Brain Cancer Cure, is featured this week in the leading innovation economy publication, Xconomy.
The projects were selected by a review committee, which includes Max Wallace, CEO of Accelerate Brain Cancer Cure.
We are pleased to launch our Fellows program for young scientific investigators. They will examine business development and strategy issues within pharmaceutical, biotechnology, financial and philanthropic organizations.
Max Wallace, CEO of Accelerate Brain Cancer Cure, provides perspective on the latest Avastin study by Genentech.
Scientists led by Dr. Luis Parada at UT Southwestern Medical Center have identified a cancer stem cell-like treatment target against glioblastoma (GBM) - the most deadly type of brain tumor.
The study, led by Antonio Iavarone at Columbia University Medical Center, pinpoints a genetic cause of some cases of glioblastoma (GBM) -- the most lethal form of brain tumor.
The research is part of the National Institute of Health's $70 million "Tissue Chip For Drug Testing" program.
University of Wisconsin-Madison research shows new prognosis tool for deadly brain cancer.
Johns Hopkins scientists hope discovery will drive drug treatments for meningioma brain tumors
A multi-partner, $8.2 million investment will develop new glioblastoma treatments.
Overall risk is low and outweighed by the reason the child needs the CT scan in the first place.
New research from the University of Wisconsin-Madison explains why the incurable brain cancer, glioblastoma multiforme (GBM), is highly resistant to current chemotherapies.
Brain tumor survivor Mark Green participated in the 15th Annual Race for Hope DC and shares his story.
American Idol® David Cook Returns To Serve As Honorary Chair
Interview Highlights ABC2's High-Risk, High-Reward Approach To Developing New, Effective Treatments for Brain Tumor Patients
ABC2's Danielle Rosenscruggs and her family are Going Gray in May to support Brain Tumor Awareness Month. Are you?
More than 1,000 participants joined forces for the 3rd Annual Florida Brain Cancer 5k Run/Walk and raised more than $140,000 on behalf of Accelerate Brain Cancer Cure.
ABC2's Race Towards A Cure team at the LA Marathon raised more than $112,000 to fund cutting-edge brain tumor research.
Max Wallace, CEO of Accelerate Brain Cancer Cure, represented the brain tumor community at a patient advocacy meeting hosted by the National Cancer Institute last month.
Max Wallace, CEO of Accelerate Brain Cancer Cure, mentors young researchers and budding biotech entrepreneurs at Duke University.
On May 7 and 8, advocates go to Capitol Hill to discuss critical policy issues that directly impact the brain tumor community.